Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.

Métais JY, Dunbar CE.

Mol Ther. 2008 Mar;16(3):439-49. doi: 10.1038/sj.mt.6300372. Review.

PMID:
18227842
2.

Genotoxicity of retroviral integration in hematopoietic cells.

Nienhuis AW, Dunbar CE, Sorrentino BP.

Mol Ther. 2006 Jun;13(6):1031-49. Review.

3.

Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.

Goyama S, Kurokawa M.

Cancer Sci. 2009 Jun;100(6):990-5. doi: 10.1111/j.1349-7006.2009.01152.x. Review.

4.
5.

Leukemogenesis of the EVI1/MEL1 gene family.

Morishita K.

Int J Hematol. 2007 May;85(4):279-86. Review.

PMID:
17483069
6.

The role of EVI1 in normal and leukemic cells.

Buonamici S, Chakraborty S, Senyuk V, Nucifora G.

Blood Cells Mol Dis. 2003 Sep-Oct;31(2):206-12. Review.

PMID:
12972028
7.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

8.

The EVI1 gene in myeloid leukemia.

Nucifora G.

Leukemia. 1997 Dec;11(12):2022-31. Review.

PMID:
9447815
10.

[Development and application of gene therapy technologies].

Ozawa K.

Uirusu. 2004 Jun;54(1):49-57. Review. Japanese.

11.

The role of EVI1 in myeloid malignancies.

Glass C, Wilson M, Gonzalez R, Zhang Y, Perkins AS.

Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):67-76. doi: 10.1016/j.bcmd.2014.01.002. Review.

PMID:
24495476
12.
13.

EVI1 and hematopoietic disorders: history and perspectives.

Nucifora G, Laricchia-Robbio L, Senyuk V.

Gene. 2006 Mar 1;368:1-11. Review.

PMID:
16314052
14.

Review: Aberrant EVI1 expression in acute myeloid leukaemia.

Hinai AA, Valk PJ.

Br J Haematol. 2016 Mar;172(6):870-8. doi: 10.1111/bjh.13898. Review.

PMID:
26729571
15.

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Baum C, von Kalle C, Staal FJ, Li Z, Fehse B, Schmidt M, Weerkamp F, Karlsson S, Wagemaker G, Williams DA.

Mol Ther. 2004 Jan;9(1):5-13. Review.

16.

Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.

Kataoka K, Kurokawa M.

Cancer Sci. 2012 Aug;103(8):1371-7. doi: 10.1111/j.1349-7006.2012.02303.x. Review.

17.

Concise review: managing genotoxicity in the therapeutic modification of stem cells.

Baum C, Modlich U, Göhring G, Schlegelberger B.

Stem Cells. 2011 Oct;29(10):1479-84. doi: 10.1002/stem.716. Review.

18.

[Advances in the study of Evi1 and mds1 genes].

Xu K, Wang L, Hao Y.

Zhonghua Xue Ye Xue Za Zhi. 1999 Jun;20(6):331-3. Review. Chinese. No abstract available.

PMID:
11721391
19.

The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).

Yuan X, Wang X, Bi K, Jiang G.

Int J Oncol. 2015 Dec;47(6):2028-36. doi: 10.3892/ijo.2015.3207. Review.

PMID:
26496831
20.

Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia.

Lopingco MC, Perkins AS.

Curr Top Microbiol Immunol. 1996;211:211-22. Review.

PMID:
8585952
Items per page

Supplemental Content

Support Center